<DOC>
	<DOCNO>NCT00244504</DOCNO>
	<brief_summary>Investigating perioperative effect moxonidine . In randomized double-blind fashion , patient undergo vascular surgery receive moxonidine 0.2 mg placebo day surgery day 4 surgery . Holter-EKG 48 h , start surgery . Repeated 12-lead EKG , measurements Troponin I BNP , clinical visitation , follow-up interview 6 12 month</brief_summary>
	<brief_title>Moxonidine Patients Undergoing Vascular Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Moxonidine</mesh_term>
	<criteria>abdominal aortic peripheral vascular surgery unstable angina , severe symptomatic heart failure ( NYHA IV ) systolic blood pressure rest &lt; 100 mmHg bradycardia ( &lt; 50/min ) high grade AV heart block creatinine clearance &lt; 30 ml/min pregnancy consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>